• 3051 Citations
20012024

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 3051 Citations
  • 60 Article
  • 25 Review article
  • 3 Comment/debate
  • 1 Short survey
Filter
Review article
2018

Growing Role of Regorafenib in the Treatment of Patients with Sarcoma

Agulnik, M. & Attia, S., Aug 1 2018, In : Targeted Oncology. 13, 4, p. 417-422 6 p.

Research output: Contribution to journalReview article

2 Scopus citations
2017

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies

Moreira, J., Tobias, A., O’Brien, M. P. & Agulnik, M., May 1 2017, In : Drugs. 77, 8, p. 843-857 15 p.

Research output: Contribution to journalReview article

21 Scopus citations

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: A systematic review and meta-analysis of randomized clinical trials

Costa, R., Carneiro, B. A., Agulnik, M., Rademaker, A. W., Pai, S. G., Villaflor, V. M., Cristofanilli, M., Sosman, J. A. & Giles, F. J., Jan 1 2017, In : Oncotarget. 8, 5, p. 8910-8920 11 p.

Research output: Contribution to journalReview article

59 Scopus citations
2016

Spotlight on lenvatinib in the treatment of thyroid cancer: Patient selection and perspectives

Costa, R., Carneiro, B. A., Chandra, S., Pai, S. G., Chae, Y. K., Kaplan, J. B., Garrett, H. B., Agulnik, M., Kopp, P. A. & Giles, F. J., Feb 29 2016, In : Drug Design, Development and Therapy. 10, p. 873-884 12 p.

Research output: Contribution to journalReview article

21 Scopus citations
2015

Targeted therapies in advanced differentiated thyroid cancer

Carneiro, R. M., Carneiro, B. A., Agulnik, M., Kopp, P. A. & Giles, F. J., Sep 1 2015, In : Cancer Treatment Reviews. 41, 8, p. 690-698 9 p.

Research output: Contribution to journalReview article

38 Scopus citations

Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas

Mohindra, N. A. & Agulnik, M., Aug 9 2015, In : Expert Opinion on Investigational Drugs. 24, 11, p. 1409-1418 10 p.

Research output: Contribution to journalReview article

3 Scopus citations
2014

Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer

Lacouture, M. E., Ciccolini, K., Kloos, R. T. & Agulnik, M., Sep 1 2014, In : Thyroid. 24, 9, p. 1329-1340 12 p.

Research output: Contribution to journalReview article

17 Scopus citations

Targeted treatment of head and neck squamous-cell carcinoma: Potential of lapatinib

Gandhi, M. D. & Agulnik, M., Feb 13 2014, In : OncoTargets and Therapy. 7, p. 245-251 7 p.

Research output: Contribution to journalReview article

7 Scopus citations
5 Scopus citations
2013

Afatinib: Emerging next-generation tyrosine kinase inhibitor for NSCLC

Nelson, V., Ziehr, J., Agulnik, M. & Johnson, M., Mar 20 2013, In : OncoTargets and Therapy. 6, p. 135-143 9 p.

Research output: Contribution to journalReview article

67 Scopus citations
2012

New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Agulnik, M., Dec 1 2012, In : Medical Oncology. 29, 4, p. 2481-2491 11 p.

Research output: Contribution to journalReview article

34 Scopus citations

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Agulnik, M., Mar 15 2012, In : Cancer. 118, 6, p. 1486-1497 12 p.

Research output: Contribution to journalReview article

19 Scopus citations
2011

Molecular therapies in thyroid cancer

Huyck, T. & Agulnik, M., Feb 8 2011, In : Pharmaceuticals. 4, 1, p. 91-100 10 p.

Research output: Contribution to journalReview article

1 Scopus citations

Occult primary

Ettinger, D. S., Agulnik, M., Cates, J. M. M., Cristea, M., Denlinger, C. S., Eaton, K. D., Fidias, P. M., Gierada, D., Gockerman, J. P., Handorf, C. R., Iyer, R., Lenzi, R., Phay, J., Rashid, A., Saltz, L., Shulman, L. N., Smerage, J. B., Varadhachary, G. R., Zager, J. S. & Zhen, W., Dec 1 2011, In : JNCCN Journal of the National Comprehensive Cancer Network. 9, 12, p. 1358-1395 38 p.

Research output: Contribution to journalReview article

17 Scopus citations

Oral complications of targeted cancer therapies: A narrative literature review

Watters, A. L., Epstein, J. B. & Agulnik, M., Jun 1 2011, In : Oral Oncology. 47, 6, p. 441-448 8 p.

Research output: Contribution to journalReview article

75 Scopus citations

Targeted therapies in bone sarcomas: Current approach and future directions

Yarber, J. L. & Agulnik, M., Jul 1 2011, In : Expert Opinion on Investigational Drugs. 20, 7, p. 973-979 7 p.

Research output: Contribution to journalReview article

13 Scopus citations
2010

Head and neck cancer: Changing epidemiology and public health implications

Kim, L., King, T. & Agulnik, M., Sep 22 2010, In : ONCOLOGY. 24, 10

Research output: Contribution to journalReview article

65 Scopus citations
2008

Management of salivary gland malignancies: Current and developing therapies

Agulnik, M., McGann, C. F., Mittal, B. B., Gordon, S. C. & Epstein, J. B., Jul 1 2008, In : Oncology Reviews. 2, 2, p. 86-94 9 p.

Research output: Contribution to journalReview article

5 Scopus citations

Molecularly targeted therapies in adult soft tissue sarcomas: Present approach and future directions

Aranha, O. & Agulnik, M., Feb 1 2008, In : Expert Opinion on Therapeutic Targets. 12, 2, p. 197-207 11 p.

Research output: Contribution to journalReview article

2 Scopus citations

Nasopharyngeal carcinoma: Current management, future directions and dental implications

Agulnik, M. & Epstein, J. B., Jul 2008, In : Oral Oncology. 44, 7, p. 617-627 11 p.

Research output: Contribution to journalReview article

61 Scopus citations

Promising newer molecular-targeted therapies in head and neck cancer

Wang, L. X. & Agulnik, M., Aug 15 2008, In : Drugs. 68, 12, p. 1609-1619 11 p.

Research output: Contribution to journalReview article

10 Scopus citations

The role of inhibitors of the epidermal growth factor in management of head and neck cancer

Brockstein, B., Lacouture, M. & Agulnik, M., Jan 1 2008, In : JNCCN Journal of the National Comprehensive Cancer Network. 6, 7, p. 696-706 11 p.

Research output: Contribution to journalReview article

12 Scopus citations
2007

Malignancies of the head and neck: The role for molecular targeted agents

Agulnik, M., Feb 1 2007, In : Expert Opinion on Therapeutic Targets. 11, 2, p. 207-217 11 p.

Research output: Contribution to journalReview article

4 Scopus citations
2006

The Changing Management of Low-Grade Astrocytomas and Oligodendrogliomas

Agulnik, M. & Mason, W. P., Dec 1 2006, In : Hematology/Oncology Clinics of North America. 20, 6, p. 1249-1266 18 p.

Research output: Contribution to journalReview article

8 Scopus citations
2004
27 Scopus citations